Cart
sales@molnova.com
MK-0873
CAS No. 500355-52-2
MK-0873( —— )
Catalog No. M34654 CAS No. 500355-52-2
MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 222 | Get Quote |
|
| 5MG | 333 | Get Quote |
|
| 10MG | 504 | Get Quote |
|
| 25MG | 790 | Get Quote |
|
| 50MG | 1086 | Get Quote |
|
| 100MG | 1431 | Get Quote |
|
| 500MG | 2871 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMK-0873
-
NoteResearch use only, not for human use.
-
Brief DescriptionMK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
-
DescriptionMK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number500355-52-2
-
Formula Weight422.44
-
Molecular FormulaC25H18N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC1CC1)(=O)C2=CN(C=3C(C2=O)=CC=CN3)C4=CC(C#CC5=CN(=O)=CC=C5)=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Gisadenafil
Gisadenafil is a selective inhibitor of phosphodiesterase 5 (PDE5) with an IC50 of 3.6 nM and prevents degradation of cGMP.
-
Siguazodan
Siguazodan is an effective, selective, orally active phosphodiesterase III ((PDE-III)) inhibitor with an IC50 of 117 nM.
-
LJI308
LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.
